|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis0 j, y( ?% N e- e- N
was to close its brain research facility in Basel, Switzerland," _5 Q6 P8 Z7 l
the story noted that this move closely followed similar cuts
% Y; ]/ V9 D$ g) x3 w$ `; @+ v% dby rival pharmaceutical firms. As a report from the European College
" [- p! [% i- [# i+ ?+ rof Neuropsychopharmacology
) U$ d( k$ E. n- @" T# X8 t# D0 @% f( Rhad warned a few months earlier, the
* Y6 N9 M; ]( S0 nabandonment of research into new psychiatric drugs by AstraZeneca,- a& ?; ^/ r0 j
GlaxoSmithKline
$ _8 @. ?" o) b* F: p( E) t4 @and others meant that “withdrawal of research
0 A* @5 V: g$ @3 tresources is a withdrawal of hope for patients and their families”.8 |0 w8 y9 V1 H }9 ~4 G1 W
! c2 V, S0 d' X, w' P& J7 B
5 Q. U9 Q, Z3 ]; ~( x( O
回复有免费下载链接5 L7 M( c0 }- T, e% I2 S; z% R
- K, R" j. O1 O% K |
-
总评分: 包包 + 20
查看全部评分
|